Noile-Immune Biotech Inc.'s market cap is currently ¥6.92B. The company's EPS TTM is ¥-3.96; its P/E ratio is ―; Noile-Immune Biotech Inc. is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is ¥-11.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in JPY
Noile-Immune Biotech Inc. Earnings and Revenue History
